1-cyclobutyl-5,6-diamino-2,4-(1H,3H)-pyrimidinedione | 75914-69-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 1-cyclobutyl-5,6-diamino-2,4-(1H,3H)-pyrimidinedione
• 英文别名: 5,6-diamino-1-cyclobutylpyrimidine-2,4-dione
• CAS: 75914-69-1
• 化学式: C₈H₁₂N₄O₂
• 分子量: 196.209
• InChiKey: XSAAMIWAJGUQKH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  101
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-cyclobutyl-5,6-diamino-2,4-(1H,3H)-pyrimidinedione 以 sodium hydroxide 、 甲酸 、 氯仿 为溶剂， 以1.4 g (38%)的产率得到3-cyclobutyl-3,7-dihydro-1H-purine-2,6-dione
  参考文献：
  名称：

  Composition and methods for the treatment of chronic obstructive airway

  摘要：

  具有对慢性阻塞性气道疾病或心脏疾病活性的化合物，其特征是具有以下结构式##STR1##其中R.sup.1为正丙基、正丁基、异丁基、正戊基、2-甲基丁基、3-甲基丁基、2,2-二甲基丙基、环丙基、环丁基、环戊基或环己基甲基，R.sup.2为氢或甲基，但要求当R.sup.1为正丙基、正丁基或异丁基时，R.sup.2为甲基，或其生理上可接受的盐。

  公开号：

  US04548818A1
• 作为产物：
  描述：

  6-amino-1-cyclobutyl-5-nitroso-2,4-(1H,3H)-pyrimidinedione 以 PtO₂ 、 N,N-二甲基甲酰胺 为溶剂， 以3.5 g (54%)的产率得到1-cyclobutyl-5,6-diamino-2,4-(1H,3H)-pyrimidinedione
  参考文献：
  名称：

  Composition and methods for the treatment of chronic obstructive airway

  摘要：

  具有对慢性阻塞性气道疾病或心脏疾病活性的化合物，其特征是具有以下结构式##STR1##其中R.sup.1为正丙基、正丁基、异丁基、正戊基、2-甲基丁基、3-甲基丁基、2,2-二甲基丙基、环丙基、环丁基、环戊基或环己基甲基，R.sup.2为氢或甲基，但要求当R.sup.1为正丙基、正丁基或异丁基时，R.sup.2为甲基，或其生理上可接受的盐。

  公开号：

  US04548818A1

文献信息

• 3-Alkylxanthines, composition and methods for the treatment of chronic
  申请人：Aktiebolaget Draco

  公开号：US04644001A1

  公开（公告）日：1987-02-17

  Compounds having activity against chronic obstructive airway disease or cardiac disease, characterized by the formula ##STR1## wherein R.sup.1 is n-propyl, n-butyl, isobutyl, n-pentyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexylmethyl, and R.sup.2 is hydrogen or methyl, provided that R.sup.2 is methyl when R.sup.1 is n-propyl, n-butyl or isobutyl, or a physiologically acceptable salt thereof.

  具有对慢性阻塞性气道疾病或心脏疾病活性的化合物，其特征在于其化学式为##STR1##其中R1为n-丙基，n-丁基，异丁基，n-戊基，2-甲基丁基，3-甲基丁基，2,2-二甲基丙基，环丙基，环丁基，环戊基或环己基甲基，R2为氢或甲基，但当R1为n-丙基，n-丁基或异丁基时，R2为甲基，或其生理上可接受的盐。
• Substituted xanthines as inhibitors of transient receptor potential cation channel subfamily c, member 5 activity
  申请人：Boehringer Ingelheim International GmbH

  公开号：US11198696B2

  公开（公告）日：2021-12-14

  The present invention relates to compounds of formula I a process for their manufacture, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment of conditions having an association with TRPC5 containing ion channels. R1, R2, R3, R4 and R5 have meanings given in the description.

  本发明涉及式 I 的化合物 其制造工艺、含有它们的药物组合物及其在治疗中的用途，特别是在治疗与含有 TRPC5 离子通道有关的疾病中的用途。R1、R2、R3、R4 和 R5 具有描述中给出的含义。
• SUBSTITUTED XANTHINE DERIVATIVES
  申请人：Boehringer Ingelheim International GmbH

  公开号：US20200190093A1

  公开（公告）日：2020-06-18

  The present invention relates to compounds of formula I a process for their manufacture, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment of conditions having an association with TRPC5 containing ion channels. R 1 , R 2 , R 3 , R 4 and R 5 have meanings given in the description.
• NOVEL SUBSTITUTED XANTHINE DERIVATIVES
  申请人：Boehringer Ingelheim International GmbH

  公开号：US20220177479A1

  公开（公告）日：2022-06-09

  The present invention relates to compounds of formula I a process for their manufacture, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment of conditions having an association with TRPC5 containing ion channels. R 1 , R 2 , R 3 , R 4 and R 5 have meanings given in the description.
• [EN] SUBSTITUTED XANTHINE DERIVATIVES<br/>[FR] DÉRIVÉS DE XANTHINE SUBSTITUÉS
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2020120450A1

  公开（公告）日：2020-06-18

  The present invention relates to compounds of formula (I) a process for their manufacture, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment of conditions having an association with TRPC5 containing ion channels. R1, R2, R3, R4 and R5 have meanings given in the description.